Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Section Navigation
			
			CDC Home


Facebook
        Twitter
        LinkedIn
        Syndicate





Current Intelligence Bulletin 29: Glycidyl Ethers										Related Pages
										October 12, 1978
DHHS (NIOSH) Publication Number 79-104

Glycidyl Ethers
The National Institute for Occupational Safety and Health (NIOSH) would like to inform the occupational health community of the possibility of adverse effects to the testes and the hemopoietic (blood forming) system in workers exposed to glycidyl ethers.
During development of a NIOSH criteria document on glycidyl ethers, a pattern of research findings emerged which indicates that some of the glycidyl ethers may be capable of producing testicular atrophy and hemopoietic abnormalities in various species of laboratory animals. Additionally, after the issuance of the June 1978 NIOSH criteria document, a 1957 study was released to NIOSH reporting testicular atrophy in laboratory rats exposed to n-butyl glycidyl ether. While none of the individual research reports are conclusive with respect to the ability of glycidyl ethers to produce permanent changes to the testes or hemopoietic system in laboratory animals, some of the changes observed may act as predisposing factor to systemic problems. NIOSH is not aware of any studies investigating the possibility of occurrence of testicular atrophy or hemopoietic abnormalities occurring in humans exposed to glycidyl ethers. The possibility of these effects occurring in humans is reason for concern. Therefore, NIOSH requests that any information regarding testicular atrophy or hemopoietic abnormalities observed in workers exposed to glycidyl ethers be reported to the NIOSH Division of Surveillance, Hazard Evaluations, and Field Studies, Industry-Wide Studies Branch, Medical Section, Telephone: (513) 684-3593.
NIOSH advises strict adherence to the detailed recommended occupational standard described in the glycidyl ethers criteria document. Particular attention should be given to appropriate medical surveillance in order to detect testicular atrophy or hemopoietic abnormalities in exposed workers. NIOSH requests that producers, distributors, users, professional associations, and unions transmit this information to their customers, employees, associates and members.

Background
Glycidyl ethers are synthetic compounds characterized by the Glycidyl ethers group and find their major use as components of epoxy resin systems. The “diglycidyl ether of bisphenol A” has been a traditional basic active ingredient of epoxy resins; other glycidyl ethers are frequently incorporated into epoxy resin systems as reactive diluents. The epoxy group of the glycidyl ethers reacts during the curing process and glycidyl ethers are therefore generally no longer present in completely cured products. Epoxy resins containing glycidyl ethers are used in a variety of applications including protective coatings, reinforced plastics, as well as bonding materials and adhesives.
Much occupational exposure to glycidyl ethers results from the use of proprietary or trade name products which do not disclose the presence of toxic agents in their formulations. This complicates efforts to take appropriate precautionary measures for the prevention of occupational disease. For example, unrecognized hazardous situations can occur where protective coatings containing epoxy resins are sprayed, thereby facilitating the inhalation of even non-volatile materials, and where there is skin contact with epoxy resins containing glycidyl ethers.
Data collected by the NIOSH National Occupational Hazards Survey (NOHS) have been used to estimate the number of people having potential occupational exposure to glycidyl ethers, as well as in identifying the industries in which the exposures occur. Pertinent data from NOHS are presented in Tables 1 and 2. NIOSH has previously estimated that approximately 1,000,000 workers are exposed to epoxy resins.1

**Table 1.** NIOSH National Occupational Hazard Survey Estimates of Occupational Exposure to Glycidyl Ethers
NIOSH National Occupational Hazard Survey Estimates of Occupational Exposure to Glycidyl Ethers
**Glycidyl Ether**
**Estimated Number of Workers
Potentially Exposed***Glycidyl Ethers**
71,000Diglycidyl Ether of Bisphenol A
36,000*n*-Butyl Glycidyl Ether
13,000Phenyl Glycidyl Ether
8,000Resorcinol Diglycidyl Ether
3,000Allyl Glycidyl Ether
2,000Octyl-Decyl Glycidyl Ether
200Diglycidyl Ether
150Isopropyl Glycidyl Ether
100Triglycidyl Glycerol Ether
70*A worker may be exposed to more than one glycidyl ether, thus the exposure estimates are not additive. Due to the difficulty of obtaining data regarding the composition of trade name products, these estimates may be low. *[return to table]*
**Exposures were entered into the NOHS data base either under the specific glycidyl ether (when the information was available) or under the general term “glycidyl ethers” (when more specific information was not available). To the extent that an exposure to a specific glycidyl ether was reported as exposure to “glycidyl ethers,” the data may underestimate occupational exposure to individual glycidyl ethers.*[return to table]*

**Table 2.** Industries Where the Majority of Occupational Exposures to Glycidyl Ethers Occur*
Industries Where the Majority of Occupational Exposures to Glycidyl Ethers Occur
Transportation Equipment
Stone, Clay, and Glass ProductsInstruments and Related Products
Medical and Other Health ServicesChemicals and Allied Products
Fabricated Metal ProductsElectrical Equipment and Supplies
Building Materials and Farm EquipmentSpecial Trade Contractors
Food and Kindred ProductsAutomotive Dealers and Service Stations
Rubber and Plastic ProductsTransportation by Air
Furniture and FixturesMiscellaneous Repair Services
Amusement and Recreation ServicesMachinery, except electrical
Leather and Leather ProductsCommunication*These are standard industrial titles from the *Standard Industrial Classification Manual.*2*[return to table]*
The National Occupational Hazard Survey, conducted between 1972 and 1974, was based on a sample of businesses selected by the Bureau of Labor Statistics and consisted of approximately 5,000 establishments employing nearly 900,000 workers in 67 standard metropolitan areas throughout the United States. This sample was representative of non-agricultural businesses covered under the Occupational Safety and Health Act of 1970.
NIOSH is not aware of any studies investigating the possible occurrence of testicular atrophy or hemopoietic abnormalities in humans exposed to glycidyl ethers. However, other effects observed in humans include dermatitis, irritation and allergic reactions. The NIOSH glycidyl ethers criteria document1 provides detailed evaluative review of reported adverse effects resulting from exposure to glycidyl ethers.

Laboratory Animals — Testicular Atrophy and Hemopoietic Abnormalities
Studies in several different research laboratories indicate that some of the glycidyl ethers are capable of producing adverse effects to the testes and hemopoietic system in various species of laboratory animals. Reported testicular abnormalities (including testicular atrophy with decreased spermatogenic activity) following exposure to glycidyl ethers are presented in Table 3. Table 4 summarizes reported hemopoietic abnormalities following exposure to glycidyl ethers, including alteration of the leukocyte count, atrophy of lymphoid tissue, and bone marrow cytotoxicity. These abnormalities were usually observed along with pneumonia and/or toxemia, and therefore may be secondary effects. However, especially in light of the generalized reduction in leukocytes and the atrophy of lymphoid tissues, the observed hemopoietic abnormalities may have been predisposing factors to pneumonia. While none of the individual research reports are conclusive with respect to the ability of glycidyl ethers to produce permanent changes to the testes or hemopoietic system in laboratory animals, the pattern of effects displayed in Tables 3 and 4 is reason for concern.
The NIOSH glycidyl ethers criteria document1 contains an evaluative review of the literature on effects of exposure to glycidyl ethers. Reported adverse effects in laboratory animals include sensitization, and skin and eye irritation, as well as mutagenic and tumorigenic activity.

**Table 3.** Reported Testicular Disorders Following Exposure to Glycidyl Ethers
Reported Testicular Disorders Following Exposure to Glycidyl Ethers
**Agent (reference)**
**Animal**
**Exposure**
**Reported Testicular Disorder**Allyl Glycidyl Ether3
Rat
400 mg/kg intramuscular injections on days 1,2,8, and 9
animals sacrificed on day 12
focal necrosis of the testis in 1 of 2 of the 3 surviving rats*n*-Butyl Glycidyl Ether4
Rat
38 ppm, 75 ppm, 150 ppm, 300 ppm by inhalation, seven hours/day, five days/week for a total of 50 exposures
atrophic testes in 5 of 10 at 300 ppm; very small testes in 1 of 10 at 300 ppm; slight patchy atrophy of the testes in 1 of 10 animals at 75 ppmDiglycidyl Ether5
Rat
125 mg/kg, 250 mg/kg cutaneous daily application, 5 days/week, total of six applications
focal necrosis of the testes3 ppm by inhalation 4 hours/day, 5 days/week total of 19 exposures
necrosis of the tubules of the testes in 1 of 15 animals0.3 ppm by inhalation, 4 hours/day, 5 days/week total of 60 exposures
poorly defined focal degeneration of the germinal epithelium in 5 of 10 animalsRabbit
single 24 hour inhalation exposure of 24 ppm
greatly atrophied testes in two animals which died on the evening of the fifth dayPhenyl Glycidyl Ehter6
Rat
1.75 ppm, 5.84 ppm, 11.20 ppm by inhalation 6 hours/day for 19 consecutive days
*Initial Report*: focal degenerative changes involving the seminiferous tubules in both gonads in 1 of 8 at 1.75 ppm, 1 of 8 at 5.84 ppm, and 3 of 8 at 11.20 ppm*Supplemental Examination*: 1 of 8 in each of 1.75, 5.84, and 11.20 ppm groups had a marked degree of gonad changeTriethylene Glycol Diglycidyl Ether7
Mouse
7208 mg/kg total dose administered in 12 intraperitoneal injection, 3 per week for four weeks, animals sacrificed 39 weeks after the first injection
testular atrophy with decreased spermatogenic activity
**Table 4.** Reported Hemopoietic Abnormalities in Animals Following Exposure to Glycidyl Ethers
Reported Hemopoietic Abnormalities in Animals Following Exposure to Glycidyl Ethers
**Agent
(reference)**
**Animal**
**Exposure**
**Reported Abnormality**Allyl Glycidyl Ether3
Rat
400 mg/kg intramuscular injections on days 1,2,8, and 9
animals sacrificed on day 12
atrophy or loss of lymphoid tissue in 2 of 3 rats decreased leukocyte countn-Butyl Glycidyl Ether3
Rat
400 mg/kg intramuscular injections for 3 consecutive days
increased leukocyte countButanediol Diglycidyl Ether8
Rat
100 mg/kg, 200 mg/kg single intraperitoneal injection
bone marrow cytotoxicityDiethylene Glycol Diglycidyl Ether8
Rat
100 mg/kg, 200 mg/kg, 400 mg/kg single intraperitoneal injection
bone marrow cytotoxicityDiglycidyl Ether5
Rat
single application of 0.5 g/kg, 1 g/kg to shaved backs
decreased leukocyte countdaily skin application of 125 mg/kg, 5 days/week for 4 weeks; skin application on days 1,2,3,4,5, and 8 of 250 mg/kg, 500 mg/kg
decreased leukocyte count increase in percentage of polymorphonuclear cellsfewer nucleated cells of the bone marrowenlarged myeloid cells in 250 and 500 mg/kg groups.lymphoid atrophy of the thymus at 500 mg/kg.3 ppm by inhalation, 4 hours/day, 5 days/week, total of 19 exposures
decreased leukocyte countRat
Single application of 1.13 g/kg to shaved back
decreased leukocyte countSingle intravenous injection of 50 mg/kg, 100 mg/kg, 200 mg/kg
decreased leukocyte count23 nucleated erythrocytes per 100 leukocytes in 100 mg/kg groupDog
25 mg/kg intravenous injection, 2 injections, six days apart, in two dogs
3 weekly injections in one dog
decreased leukocyte countPhenyl Glycidyl Ether3
Rat
400 mg/kg intramuscular injections for 3 consecutive days
increased leukocyte count
NIOSH Recommendation
Reports from different laboratories present a pattern of findings indicating that some of the glycidyl ethers may be capable of producing testicular atrophy and hemopoietic abnormalities in various species of laboratory animals. While none of the individual research reports are conclusive with respect to the ability of glycidyl ethers to produce permanent changes to the testes or hemopoietic system in laboratory animals, some of the changes observed may act as predisposing factors to systemic problems. NIOSH is not aware of any studies investigating the possible occurrence of testicular atrophy or hemopoietic abnormalities in humans exposed to glycidyl ethers. The possibility of these effects occurring in humans is reason for concern. Therefore, the occupational health community is advised of the possibility of these effects appearing in workers exposed to glycidyl ethers.
The “NIOSH Criteria for a Recommended Standard......Occupational Exposure to Glycidyl Ethers” was transmitted to the Occupational Safety and Health Administration (OSHA), Department of Labor, on June 30, 1978.1 This criteria document contains detailed recommendations regarding maximum exposure levels medical surveillance, labeling and posting, personal protective clothing an equipment, informing employees of hazards, work practices, sanitation, monitoring and recordkeeping requirements as well as sampling and analytical procedures. Existing occupational exposure limits for specific glycidyl ethers are listed in Table 5.

Table 5. Existing Occupational Exposure Limits for Specific Glycidyl Ethers
Existing Occupational Exposure Limits for Specific Glycidyl Ethers
**Present OSHA
Exposure Standard9**
**NIOSH Recommended
Exposure Standard1
(Ceiling)**Allyl Glycidyl Ether
10 ppm (45 mg/cum)*
45 mg/cu m (9.6 ppm)n-Butyl Glycidyl Ether
50 ppm (270 mg/cu m)**
30 mg/ cu m (5.6 ppm)Diglycidyl Ether
0.5 ppm (2.8 mg/cu m)*
1 mg/cu m (0.2 ppm)Isopropyl Glycidyl Ether
50 pp (240 mg/cu m)**
240 mg/cu m (50 ppm)Phenyl Glycidyl Ether
10 ppm (60 mg/cu m)**
5 mg/cu m (1 ppm)*Ceiling
**8-hour time-weighted average
NIOSH advises strict adherence to this detailed recommended occupational standard for glycidyl ethers described in the NIOSH criteria document. Particular attention should be given to appropriate medical surveillance in order to detect testicular atrophy or hemopoietic abnormalities in exposed workers.
NIOSH requests that any information regarding testicular atrophy or hemopoietic abnormalities in workers exposed to glycidyl ethers be reported to the NIOSH Division of Surveillance, Hazard Evaluations, and Field Studies, Industry-Wide Studies Branch, Medical Section, Telephone: (513) 684-3593.
*[signature]*
J. Michael Lane, M.D.
Acting Director

References
NIOSH Criteria for a Recommended Standard .... Occupational Exposure to Glycidyl Ethers. United States Department of Health, Education, and Welfare. Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, Cincinnati (1978), in press.
Standard Industrial Classification Manual 1967. Executive Office of the President, Bureau of the Budget, Washington (1967).
Kodama, J. K., R. J. Guzman, M. K. Dunlap, G. S. Loquvam, R. Lima and C. H. Hine: Some Effects of Epoxy Compounds on the Blood. Arch. Environ. Health 2: 56-67 1961.
Anderson, H. H., C. H. Hine, R. J. Guzman and J. S. Wellington: Chronic Vapor Toxicity of *n*-Butyl Glycidyl Ether. Confidential Report to Shell Development Company, Emeryville, California from Department of Pharmacology and Experimental Therapeutics, University of California School of Medicine, San Francisco, U. C. Report No. 270, February 4, 1957.
Hine, C. H., J. K. Kodama, R. J. Guzman, M. K. Dunlap, K. Lima and G. S. Loquvwam: Effects of Diglycidyl Ether on Blood of Animals. Arch. Environ. Health 2: 37-50 1961.
Terrill, J. B. and H. J. Trochimowicz: A Two-Generation Reproduction and Mutagenic Study in Rats. E. I. du Pont de Nemours and Company, Haskel Laboratory for Toxicology and Industrial Medicine, Haskell Laboratory Report No. 163-75, Wilmington, Delaware, April 7, 1975.
Shimkin, M. B., J, H. Weisburger, E. K. Weisburger, N. Gubareff and Suntzeff: Bioassay of 29 Alkylating Chemicals by the Pulmonary-Tumo Response in Strain A Mice. J. Nat. Cancer Inst. 36: 915-935 (1966).
Hendry, J. A., R. F. Homer, F. L. Rose and A. L. Walpole: Cytotoxic Agents: II, Bis-Epoxides and Related Compounds. Brit. J. Pharmacol. 6: 235-255
Occupational Safety and Health General Industry Standards. United State Department of Labor, Occupational Safety and Health Administration, OSHA Publication 2206, Washington (1976). (29 CFR 1910.1000)
Identifiers and Synonyms for Allyl Glycidyl Ether
Chemical Abstracts Service Registry Number 106-92-3
NIOSH RTECS Number RRO875000
Chemical Formula C6H10O2
Identifiers and Synonyms for Allyl Glycidyl Ether
AGE

Ether, Allyl 2,3-epoxypropylAllyl 2,3-Epoxypropyl Ether

Glycidyl Allyl EtherAllyl Glycidyl Ether

Oxirane, [(2-Propenyloxy)methyl]-1-Allyloxy-2,3-epoxypropane

Propane, 1-(Allyloxy)-2,3-epoxy-1,2-Epoxy-3-allyoxypropaneIdentifiers and Synonyms for *n*-Butyl Glycidyl Ether
Chemical Abstracts Service Registry Number 2426-08-6
NIOSH RTECS Number TX4200000
Chemical Formula C7H14O2
Identifiers and Synonyms for n-Butyl Glycidyl Ether
BGE

ERL 08101-Butoxy-2, 3-epoxypropane

Ether, Butyl 2,3-Epoxypropyl3-Butoxy-1, 2-epoxypropane

Ether, Butyl GlycidylButyl Glycidyl Ether

Glycidyl Butyl Ether*n*-Butyl Glycidyl Ether

Oxirane, (Butoxymethyl)-2,3-Epoxypropyl Butyl Ether

Propane, 1-Butoxy-2,3-epoxy-Identifiers and Synonyms for Diglycidyl Ether
Chemical Abstracts Service Registry Number 2238-07-5
NIOSH RTECS Number KN2350000
Chemical Formula C6H10O3
Identifiers and Synonyms for Diglycidyl Ether
Bis(2,3-Epoxypropyl) Ether

Ether, DiglycidylDGE

Glycidyl EtherDi(2,3-epoxy)propyl Ether

NSC 54739Diglycidyl Ether

Oxirane, 2,2′-[Oxybis(methylene)]bis-Ether, Bis(2,3-epoxypropyl)Identifiers and Synonyms for Diglycidyl Ether of Bisphenol A
Chemical Abstracts Service Registry Number 1675-54-3
NIOSH RTECS Number TX3800000
Chemical Formula C21H24O4
Identifiers and Synonyms for Diglycidyl Ether of Bisphenol A
4,4′-B is (2,3-epoxypropoxy) diphenyldimethylmethane2,2-Bis [*p*-(2,3-epoxypropoxy)phenyl]propane2,2-Bis [4-(2,3-epoxypropoxy)phenyl]propaneBis(4-glycidyloxyphenyl)dimethylmethane2,2-Bis(*p*-glycidyloxyphenyl)propane2,2-Bis(4-glycidyloxyphenyl)propaneBis(4-hydroxyphenyl)dimethylmethane Diglycidyl Ether2,2-Bis(*p*-hydroxyphenyl)propane Diglycidyl Ether2,2-Bis(4-hydroxyphenyl)propane Diglycidyl EtherBisphenol A Diglycidyl EtherD.E.R. 332Dian Diglycidyl EtherDiglycidyl Bisphenol ADiglycidyl Bisphenol A EtherDiglycidyl Diphenylolpropane EtherDiglycidyl Ether of 2,2-Bis(*p*-hydroxyphenyl)propaneDiglycidyl Ether of 2,2-Bis(4-hydroxyphenyl)propaneDiglycidyl Ether of Bisphenol ADiglycidyl Ether of 4,4′-Isopropylidenediphenol4,4′-Dihydroxydiphenyldimethylmethane Diglycidyl Ether*p*,*p*‘-Dihydroxydiphenyldimethylmethane Diglycidyl EtherDiomethane Diglycidyl EtherEPI-REZ 510Epoxide AERL-27744,4′-Isopropylidenebis[1-(2,3-epoxypropoxy)benzene]4,4′-Isopropylidenediphenol Diglycidyl Ether2,2′[(1-Methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxiraneOxirane, 2,2′ [(1-Methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-Propane, 2-2-Bis [(*p*-(2,3-epoxpropoxy)phenyl]-Identifiers and Synonyms for Isopropyl Glycidyl Ether
Chemical Abstracts Service Registry Number 4016-14-2
NIOSH RTECS Number TZ3500000
Chemical Formula C6H12O2
Identifiers and Synonyms for Isopropyl Glycidyl Ether
1,2-Epoxy-3-isopropoxypropane

Isopropyl Glycidyl EtherGlycidyl Isopropyl Ether

[(1-Methylethoxy)methyl] oxiraneIGE

Oxirane, [(1-Methylethoxy)methyl]-3-Isopropoxy-1,2-epoxypropane

Propane, 1,2-Epoxy-3-isopropoxy(Isopropoxymethyl)oxiraneIdentifiers and Synonyms for Phenyl Glycidyl Ether
Chemical Abstracts Service Registry Number 122-60-1
NIOSH RTECS Number TZ3675000
Chemical Formula C9H10O2
Identifiers and Synonyms for Phenyl Glycidyl Ether
Benzene, (2,3-Epoxypropoxy)-

3-Phenoxy-1,2-propylene Oxide1,2-Epoxy-3-phenoxypropane

(Phenoxymethyl)oxirane2,3-Epoxypropyl Phenyl Ether

Phenoxypropene Oxide2,3-Epoxypropylphenyl Ether

Phenoxypropylene OxideEther, 2,3-Epoxypropyl Phenyl

*y*-Phenoxypropylene OxideGlycidol Phenyl Ether

Phenyl 2,3-Epoxypropyl EtherGlycidyl Phenyl Ether

Phenyl Glycidyl EtherOxirane, (Phenoxymethyl)-

Phenylglycidyl EtherPGE

3-Phenyloxy-1,2-epoxypropanePhenol Glycidyl Ether

Propane, 1,2-Epoxy-3-phenoxy1-Phenoxy-2,3-epoxypropane3-Phenoxy-1,2-epoxypropaneIdentifiers and Synonyms for Resorcinol Diglycidyl Ether
Chemical Abstracts Service Registry Number 101-90-6
NIOSH RTECS Number VH1050000
Chemical Formula C12H14 04
Araldite ERE 1359
Benzene, *m*-Bis(2,3-epoxypropoxy)-
Diglycidyl Resorcinol Ether*m*-Bis(2,3-epoxypropoxy)benzene
1,3-Bis(2,3-epoxypropoxy)benzene
NCI – C54966
Oxirane, 2,2′- [1,3-Phenylenebis(oxymethylene)]bis-
2,2- [1,3-Phenylenebis(oxymethylene)]bisoxirane
RDGE
Resorcinol Bis(2,3-epoxypropyl) Ether
Resorcinol Diglycidyl Ether
Resorcinol Glycidyl Ether
Resorcinyl Diglycidyl Ether

Chemical Structures of Some Glycidyl Ethers
Chemical Structures of Some Glycidyl Ethers
allyl glycidyl ether
allyl glycidyl ether*n*-butyl glycidyl ether
n-butyl glycidyl etherdiglycidyl ether
diglycidyl etherdiglycidyl ether of bisphenol A
diglycidyl ether of bisphenol Aisopropyl glycidyl ether
isopropyl glycidyl etherphenyl glycidyl ether
phenyl glycidyl etherresorcinol diglycidyl ether
resorcinol diglycidyl ether
							
					
						Page last reviewed:  June 6, 2014					Content source: 	National Institute for Occupational Safety and Health homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue